Citius Pharmaceuticals (CTXR) P/E (2017 - 2026)
Citius Pharmaceuticals (CTXR) P/E from Jul 6, 2017 to Jul 21, 2026. The TTM Citius Pharmaceuticals (CTXR) P/E is -0.20. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Citius Pharmaceuticals (CTXR)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.20 | -28.35% |
| 2025 | -0.27 | -44.09% |
| 2024 | -0.49 | -86.32% |
| 2023 | -3.56 | +3.77% |
| 2022 | -3.43 | -62.65% |
| 2021 | -9.19 | +294.38% |
| 2020 | -2.33 | +51.58% |
| 2019 | -1.54 | +47.30% |
| 2018 | -1.04 | -97.32% |
| 2017 | -38.94 | N/A |
Comparison Citius Pharmaceuticals (CTXR) P/E with competitors
Citius Pharmaceuticals (CTXR) P/E is -0.20.